IndiaOne Finance - Company Dashboard

Governance Classic Home

Amanta Healthcare LtdPharmaceuticalsINE084K01015Standalone₹189.15-3.85 (-1.99%)Jun-26

Valuation

Market Cap₹737.56 Cr

TTM PE45.66x

Forward PE37.39x

PEG-5.59

Book Value₹56.71

P/B3.35x

TTM EPS₹4.16

Fwd EPS₹5.08

TTM Revenue₹291.17 Cr

TTM PAT₹14.68 Cr

TTM EBITDA₹59.50 Cr

TTM EBIT₹40.73 Cr

Last Qtr PAT₹3.31 Cr

Last Qtr EBITDA₹14.54 Cr

Last Qtr EBIT₹9.85 Cr

Profitability

ROE6.67%

ROCE9.00%

TTM NPM5.04%

TTM EBITDA %20.43%

Curr OPM4.77%

Last OPM7.03%

Curr NPM—

Last NPM—

Curr EPS₹0.85

Last EPS₹1.61

Balance sheet

Equity₹38.83 Cr

Reserve₹181.38 Cr

Total Debt₹234.42 Cr

D/E1.06x

Interest %181.27%

Curr Interest₹6.00 Cr

Price / range

Close₹189.95

vs 52W High-9.53%

vs 52W Low+104.03%

MA50—

MA200—

Returns

1D0.00%

1W-4.71%

1M+9.84%

3M+28.89%

6M+94.30%

1Y+35.73%

2Y—

3Y—

5Y—

Diwali+77.44%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	68.80+5.3%	76.99	74.49	70.89	65.31	287.68
Other Income	0.64	1.66	0.68	0.07	0.96	3.37
Total Income	69.45+4.8%	78.66	75.16	70.96	66.27	291.05
Interest	6	4.25	5.06	5.15	6.29	20.75
Expenditure	-64.95-5.9%	-71.04	-68.86	-66.05	-61.34	-267.29
PBDT	0	0	0	0	0	0
EBITDA	14.54-2.4%	14.95	15.36	14.65	14.90	59.87
Depreciation	-4.69	-4.75	-4.67	-4.66	-4.64	-18.73
EBIT	9.85-4.0%	10.20	10.69	9.99	10.26	41.14
PBT	4.49-8.9%	7.62	6.30	2.28	4.93	21.12
Tax	-1.18	-2.09	-1.68	-1.07	-1.42	-6.25
Equity	3.88	38.83	0	3.43	2.88	38.83
OPM	6.47	9.69	8.46	3.21	7.44	7.26
Net Profit	3.31-5.7%	5.53	4.63	1.21	3.51	14.88
NPM	4.77	7.03	6.21	1.71	5.30	5.11
EPS	0.85-30.3%	1.61	1.35	0.35	1.22	4.33

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	287.68
Other Income	3.37
Total Income	291.05
Expenditure	-267.29
Interest	-20.75
PBDT	0
EBITDA	59.87
Depreciation	-18.73
EBIT	41.14
PBT	21.12
Tax	-6.25
Equity	38.83
OPM (%)	7.26
Net Profit	14.88
NPM (%)	5.11
EPS (Rs)	4.33
CEPS	4.33

Metric	FY25-26
Revenue	287.68
Other Income	3.37
Total Income	291.05
Interest	20.75
Expenditure	-267.29
PBDT	0
EBITDA	59.87
Depreciation	-18.73
EBIT	41.14
PBT	21.12
Tax	-6.25
Equity	38.83
OPM	7.26
Net Profit	14.88
NPM	5.11
EPS	4.33

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	287.68
Other Income	3.37
Total Income	291.05
Expenditure	-267.29
Interest	-20.75
PBDT	0
EBITDA	59.87
Depreciation	-18.73
EBIT	41.14
PBT	21.12
Tax	-6.25
Equity	38.83
OPM (%)	7.26
Net Profit	14.88
NPM (%)	5.11
EPS (Rs)	4.33
CEPS	4.33

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split